Reports cash position of $2.31B as of March 31.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on HZNP:
- Horizon Pharma put volume heavy and directionally bearish
- TD Cowen merger specialist to hold an analyst/industry conference call
- Viridian Therapeutics initiated with an Overweight at Wells Fargo
- Horizon Therapeutics announces FDA approval of Tepezza indication update
- Horizon announces results from Tepezza trial in patients with CAS, TED